Transcarotid artery revascularization (TCAR), using interoperative flow reversal is a unique, hybrid operation utilized in treating critical carotid artery stenosis. Over the past decade, TCAR has been increasingly used to treat asymptomatic carotid artery disease and has a similar risk profile to traditional carotid endarterectomy (CEA). Postoperative length of stay (LOS) has a significant impact on cost-effectiveness as well as quality outcomes in this expanded setting.